Conference 2025 Abstracts

Oral presentations – 10 minutes duration with 5 minutes for questions
Poster presentations – hard copy posters will be on display with authors in attendance at a specified day/time to discuss their research with interested delegates. 

All abstracts are to be submitted under one of the following themes:

• Pharmaceutical science
• Pharmacy practice
• Pharmacy education

All abstracts must be submitted via the online abstract submission portal.

Abstract title: The abstract title must be in sentence case (only capitalise the first letter of the first word in the title – like you would in a sentence. Proper nouns must also have a capital). The title should be specific about the abstract’s content. Use short titles and standard abbreviations (expand at its first instance). The maximum title length is 18 words.

Author names and affiliations: You must enter each authors’ name and affiliation including the city, state and country. You must also indicate who will be the presenting author.

Abstract text: The abstract text must not exceed 300 words, excluding the abstract title and author details.

Text must be submitted as plain text without formatting. A limited number of symbols are available from the Special Character Keyboard (see below).

Tables, graphs, and charts are NOT permitted in abstracts.

Text must be single-spaced and in upper and lowercase letters.

Oral and poster abstracts should follow the following format:
Introduction: text
Aims: text
Methods: text
Results: text
Discussion: text

Text to begin immediately following the heading and without additional line spacing.

All text, including the heading, should be entered in sentence case (do not type in CAPITAL LETTERS)

Avoid reference to institution names, locations, or funding sources in the abstract.

Please carefully check all text for errors before submission as the quality of your abstract in this regard may significantly affect the outcome of the reviewers’ evaluation and scoring of your abstract.

Abstracts must be submitted via the online abstract submission site.

All submitted abstracts will be reviewed by at least 2 reviewers.

In evaluating each abstract, reviewers will be unaware of authors or institutions involved with the work described in the abstract (Abstracts will be suitably anonymised by the program secretariat before being sent out to reviewers).

The Program Committee will assign accepted abstracts either to oral or poster presentation, and the reviewers’ decision is final.

The Organising Committee reserves the right to accept or decline any submissions and to select the presentation format.

Notification of the outcome of the review and acceptances will be sent to the contact person (this should be the first presenting author) by Wednesday 15 October 2025.

Only the contact person will be notified of acceptance or non- acceptance, and it is their responsibility to notify all other authors about the outcome of the reviewers’ decision.

For all accepted abstracts, further details regarding the oral presentation (PowerPoint presentation) and poster presentation (poster size, format, style and layout etc) will be communicated to the contact person as appropriate.

All presenting authors (maximum of two) must be registered for the conference to be able to present the abstract. The deadline for presenting author registration is Friday 24 October 2025.

Accepted abstracts will be published in the program only if the presenting author has registered for the conference.

Enquiries regarding abstracts should be emailed to apsa@expertevents.com.au.